GlassScriptPhysician profile
Rizwana Khan
NPI 1154558419
$1,404.76
in general payments reported to CMS, 2019-2025
16 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2021: $227 · 2022: $107 · 2023: $160 · 2024: $231 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $254.80 | 2019 | |
| Abbott Laboratories | $237.31 | 2021-2025 | Optis, Freestyle Libre 3 |
| Novo Nordisk INC | $184.50 | 2022-2025 | Wegovy |
| Pfizer INC. | $163.33 | 2021-2025 | |
| Shockwave Medical, INC | $125.00 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $111.91 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.37 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $61.92 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $49.20 | 2023-2025 | Farxiga, Lokelma |
| Amgen INC. | $32.09 | 2024 | Otezla, Repatha |
| Biotronik Nro, INC. | $27.96 | 2025 | Prospera |
| Edwards Lifesciences Corporation | $24.00 | 2025 | Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $20.78 | 2022 | |
| Lilly USA, LLC | $18.63 | 2025 | Zepbound |
| Daiichi Sankyo INC. | $14.00 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rizwana Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.